ABAXIS approves repurchase of $40.

ABAXIS approves repurchase of $40,000,000 of common stock ABAXIS, Inc. today announced that its Plank of Directors has authorized the repurchase as high as an aggregate of $40,000,000 of its Common Share.3 billion in 2016 Robotic technology has been utilized to supply medical care about a limited basis over the past two decades, helping to make surgical treatments and physical rehabilitation better and effective, and safer for patients azithromycin 500 mg . Recent developments in robots’ technological features, combined with improving financial environment for medical solutions delivery and payments, are driving improved demand for surgical, telemedicine-based and assistive robots.